Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
1.77
0.00 (0.00%)
At close: Aug 15, 2025, 3:49 PM
0.00% (1D)
| Bid | 1.26 |
| Market Cap | 30.75M |
| Revenue (ttm) | 3.49M |
| Net Income (ttm) | -147.15M |
| EPS (ttm) | -8.58 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | -4.17 |
| Analyst | Buy |
| Ask | 2.26 |
| Volume | 80,644 |
| Avg. Volume (20D) | 161,341 |
| Open | 1.75 |
| Previous Close | 1.77 |
| Day's Range | 1.75 - 1.80 |
| 52-Week Range | 0.95 - 4.74 |
| Beta | 3.04 |
About MURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-20.26%
Mural Oncology shares are trading lower after the ...
Unlock content with
Pro Subscription
4 months ago
+133.98%
Mural Oncology shares are trading higher after the company announced plans to explore strategic alternatives and discontinue clinical development of nemvaleukin.
1 week ago · fool.com
Mural Oncology (MURA) Q2 Loss Widens 49%Mural Oncology (MURA) Q2 Loss Widens 49%